RT Journal Article
SR Electronic
T1 Group testing: revisiting the ideas
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.29.20142323
DO 10.1101/2020.06.29.20142323
A1 Viktor Skorniakov
A1 Remigijus Leipus
A1 Gediminas Juzeliūnas
A1 Kęstutis Staliūnas
YR 2021
UL http://medrxiv.org/content/early/2021/03/11/2020.06.29.20142323.abstract
AB The task of identification of randomly scattered ‘bad’ items in a fixed set of objects is a frequent one, and there are many ways to deal with it. ‘Group testing’ (GT) refers to the testing strategy aiming to effectively replace the inspection of single objects by the inspection of groups spanning more than one object. First announced by Dorfman in 1943, the methodology has underwent vigorous development, and though many related research still takes place, the ground ideas remain the same. In the present paper, we revisit two classical GT algorithms: the Dorfman’s algorithm and the halving algorithm. Our fresh treatment of the latter and expository comparison of the two is devoted to dissemination of GT ideas which are so important in the current COVID-19 induced pandemic situation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementSecond author is supported by grant S-COV-20-4 from the Research Council of Lithuania.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:There is no need for IRB approval for this study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData sharing is not applicable to this article as no new data were created or analysed in this study.